Company Badge
USPTO Data Jan 1 1976 - Oct 20 2026
9 Patents
#16 in Utrecht
#682 in Netherlands
Am-Pharma B.v.
Forward Citations = 36
25 inventors:
Am-Pharma B.v.
% Expired Patents = 11.1
EPO Patents = 9
Trademarks = 1
Forward Citations = 36
Loading Chart...
Loading Chart...
25 inventors (with patents filed for the assignee):
Willem Raaben (6 out of 6 patents)
Luigi Johannes Cornelius Jonk (6 out of 6 patents)
Erik Jan Van Den Berg (6 out of 6 patents)
4. Andrea Van Elsas (4 out of 19 patents)
5. José Luis Millán (4 out of 5 patents)
6. Markwin Paul Velders (2 out of 2 patents)
7. Roelof Peter Pickkers (2 out of 2 patents)
8. Stephen Edward Connor (1 out of 3 patents)
9. Abhinav Alok Shukla (1 out of 1 patent)
10. Heather Bethea Horne (1 out of 1 patent)
11. Susan Cook (1 out of 1 patent)
12. Timothy Martin Kelly (1 out of 3 patents)
13. Victoria Anne Dowling (1 out of 1 patent)
14. Mialy Fanjamalala Ramaroson (1 out of 1 patent)
15. Suzanne Heemskerk (1 out of 1 patent)
9 patents:
Company Overview
Am-Pharma B.V. is a biopharmaceutical company focused on the development of innovative therapeutics for the treatment of kidney diseases. Their lead product candidate, recAP (recombinant human Alkaline Phosphatase), is currently in Phase III clinical trials for the treatment of Acute Kidney Injury (AKI) and Chronic Kidney Disease (CKD). Am-Pharma is committed to improving the lives of patients with kidney diseases through the development of novel and effective treatments.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Am-Pharma B.v.. Retrieved from https://idiyas.com/company/am-pharma-b-v
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
9 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]